Global Regenerative Medicine Market 2024-2028

The regenerative medicine market is forecasted to grow by USD 70110.07 mn during 2023-2028, accelerating at a CAGR of 23.31% during the forecast period. The report on the regenerative medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, increasing support from public and private healthcare organizations, and increasing adoption of stem cell therapy.

Market Scope
Base Year	2023
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	22.43%
CAGR	23.31%
Incremental Value	$70110.07mn

Technavio's regenerative medicine market is segmented as below:

By Application

Oncology
Musculoskeletal
Dermatology
Immunology and inflammation and others

By Technology

Cell
tissue-based
Gene therapy

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing number of clinical trials as one of the prime reasons driving the regenerative medicine market growth during the next few years. Also, emerging technological advances in global regenerative medicine market and increasing prominence of chimeric antigen receptor t-cell (CAR-T) therapies will lead to sizable demand in the market.

The report on the regenerative medicine market covers the following areas:

Regenerative medicine market sizing
Regenerative medicine market forecast
Regenerative medicine market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading regenerative medicine market vendors that include AbbVie Inc., Amgen Inc., Baxter International Inc., Becton Dickinson and Co., Cook Group Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Integra Lifesciences Corp., Johnson and Johnson, Medtronic Plc, Merck and Co. Inc., Mesoblast Ltd., MiMedx Group Inc., Novartis AG, Nuvasive Inc., Organogenesis Holdings Inc., Smith and Nephew plc, Thermo Fisher Scientific Inc., Vericel Corp., and Zimmer Biomet Holdings Inc.. Also, the regenerative medicine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR41171

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Technology
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global regenerative medicine market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global regenerative medicine market 2018 - 2022 ($ million)
4.2 Application Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 Technology Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Technology Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

6.1 Market segments
Exhibit 30: Chart on Application - Market share 2023-2028 (%)
Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Oncology - Market size and forecast 2023-2028
Exhibit 34: Chart on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Oncology - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
6.4 Musculoskeletal - Market size and forecast 2023-2028
Exhibit 38: Chart on Musculoskeletal - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Musculoskeletal - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Musculoskeletal - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Musculoskeletal - Year-over-year growth 2023-2028 (%)
6.5 Dermatology - Market size and forecast 2023-2028
Exhibit 42: Chart on Dermatology - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Dermatology - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Dermatology - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Dermatology - Year-over-year growth 2023-2028 (%)
6.6 Immunology and inflammation and others - Market size and forecast 2023-2028
Exhibit 46: Chart on Immunology and inflammation and others - Market size and forecast 2023-2028 ($ million)
Exhibit 47: Data Table on Immunology and inflammation and others - Market size and forecast 2023-2028 ($ million)
Exhibit 48: Chart on Immunology and inflammation and others - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Immunology and inflammation and others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Application
Exhibit 50: Market opportunity by Application ($ million)
Exhibit 51: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Technology

7.1 Market segments
Exhibit 52: Chart on Technology - Market share 2023-2028 (%)
Exhibit 53: Data Table on Technology - Market share 2023-2028 (%)
7.2 Comparison by Technology
Exhibit 54: Chart on Comparison by Technology
Exhibit 55: Data Table on Comparison by Technology
7.3 Cell and tissue-based - Market size and forecast 2023-2028
Exhibit 56: Chart on Cell and tissue-based - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Cell and tissue-based - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Cell and tissue-based - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Cell and tissue-based - Year-over-year growth 2023-2028 (%)
7.4 Gene therapy - Market size and forecast 2023-2028
Exhibit 60: Chart on Gene therapy - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Gene therapy - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Gene therapy - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Gene therapy - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Technology
Exhibit 64: Market opportunity by Technology ($ million)
Exhibit 65: Data Table on Market opportunity by Technology ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 Japan - Market size and forecast 2023-2028
Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 115: AbbVie Inc. - Overview
Exhibit 116: AbbVie Inc. - Product / Service
Exhibit 117: AbbVie Inc. - Key news
Exhibit 118: AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Exhibit 119: Amgen Inc. - Overview
Exhibit 120: Amgen Inc. - Product / Service
Exhibit 121: Amgen Inc. - Key offerings
12.5 Baxter International Inc.
Exhibit 122: Baxter International Inc. - Overview
Exhibit 123: Baxter International Inc. - Business segments
Exhibit 124: Baxter International Inc. - Key news
Exhibit 125: Baxter International Inc. - Key offerings
Exhibit 126: Baxter International Inc. - Segment focus
12.6 Becton Dickinson and Co.
Exhibit 127: Becton Dickinson and Co. - Overview
Exhibit 128: Becton Dickinson and Co. - Business segments
Exhibit 129: Becton Dickinson and Co. - Key news
Exhibit 130: Becton Dickinson and Co. - Key offerings
Exhibit 131: Becton Dickinson and Co. - Segment focus
12.7 Cook Group Inc.
Exhibit 132: Cook Group Inc. - Overview
Exhibit 133: Cook Group Inc. - Product / Service
Exhibit 134: Cook Group Inc. - Key offerings
12.8 Integra Lifesciences Corp.
Exhibit 135: Integra Lifesciences Corp. - Overview
Exhibit 136: Integra Lifesciences Corp. - Business segments
Exhibit 137: Integra Lifesciences Corp. - Key news
Exhibit 138: Integra Lifesciences Corp. - Key offerings
Exhibit 139: Integra Lifesciences Corp. - Segment focus
12.9 Medtronic Plc
Exhibit 140: Medtronic Plc - Overview
Exhibit 141: Medtronic Plc - Business segments
Exhibit 142: Medtronic Plc - Key news
Exhibit 143: Medtronic Plc - Key offerings
Exhibit 144: Medtronic Plc - Segment focus
12.10 Merck and Co. Inc.
Exhibit 145: Merck and Co. Inc. - Overview
Exhibit 146: Merck and Co. Inc. - Business segments
Exhibit 147: Merck and Co. Inc. - Key news
Exhibit 148: Merck and Co. Inc. - Key offerings
Exhibit 149: Merck and Co. Inc. - Segment focus
12.11 MiMedx Group Inc.
Exhibit 150: MiMedx Group Inc. - Overview
Exhibit 151: MiMedx Group Inc. - Business segments
Exhibit 152: MiMedx Group Inc. - Key news
Exhibit 153: MiMedx Group Inc. - Key offerings
Exhibit 154: MiMedx Group Inc. - Segment focus
12.12 Novartis AG
Exhibit 155: Novartis AG - Overview
Exhibit 156: Novartis AG - Business segments
Exhibit 157: Novartis AG - Key offerings
Exhibit 158: Novartis AG - Segment focus
12.13 Nuvasive Inc.
Exhibit 159: Nuvasive Inc. - Overview
Exhibit 160: Nuvasive Inc. - Business segments
Exhibit 161: Nuvasive Inc. - Key news
Exhibit 162: Nuvasive Inc. - Key offerings
Exhibit 163: Nuvasive Inc. - Segment focus
12.14 Organogenesis Holdings Inc.
Exhibit 164: Organogenesis Holdings Inc. - Overview
Exhibit 165: Organogenesis Holdings Inc. - Product / Service
Exhibit 166: Organogenesis Holdings Inc. - Key offerings
12.15 Smith and Nephew plc
Exhibit 167: Smith and Nephew plc - Overview
Exhibit 168: Smith and Nephew plc - Business segments
Exhibit 169: Smith and Nephew plc - Key news
Exhibit 170: Smith and Nephew plc - Key offerings
Exhibit 171: Smith and Nephew plc - Segment focus
12.16 Thermo Fisher Scientific Inc.
Exhibit 172: Thermo Fisher Scientific Inc. - Overview
Exhibit 173: Thermo Fisher Scientific Inc. - Business segments
Exhibit 174: Thermo Fisher Scientific Inc. - Key news
Exhibit 175: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 176: Thermo Fisher Scientific Inc. - Segment focus
12.17 Vericel Corp.
Exhibit 177: Vericel Corp. - Overview
Exhibit 178: Vericel Corp. - Product / Service
Exhibit 179: Vericel Corp. - Key news
Exhibit 180: Vericel Corp. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 181: Inclusions checklist
Exhibit 182: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 183: Currency conversion rates for US$
13.4 Research methodology
Exhibit 184: Research methodology
Exhibit 185: Validation techniques employed for market sizing
Exhibit 186: Information sources
13.5 List of abbreviations
Exhibit 187: List of abbreviations